|
CRCP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.289800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.937600E-01 |
| Normal-vs-Stage2 |
9.544600E-01 |
| Normal-vs-Stage3 |
6.344600E-01 |
| Normal-vs-Stage4 |
8.312000E-01 |
| Stage1-vs-Stage2 |
8.881400E-01 |
| Stage1-vs-Stage3 |
5.260000E-01 |
| Stage1-vs-Stage4 |
9.924600E-01 |
| Stage2-vs-Stage3 |
7.023000E-01 |
| Stage2-vs-Stage4 |
9.081800E-01 |
| Stage3-vs-Stage4 |
6.477000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.231800E-01 |
| Normal-vs-AfricanAmerican |
5.244200E-01 |
| Normal-vs-Asian |
5.192600E-01 |
| Caucasian-vs-AfricanAmerican |
8.204600E-01 |
| Caucasian-vs-Asian |
5.400600E-01 |
| AfricanAmerican-vs-Asian |
4.145400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.052000E-01 |
| Normal-vs-Female |
2.343400E-01 |
| Male-vs-Female |
3.289000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.961600E-01 |
| Normal-vs-Extreme_Weight |
9.708200E-01 |
| Normal-vs-Obese |
7.157600E-01 |
| Normal-vs-Extreme_Obese |
9.199000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.156000E-01 |
| Normal_Weight-vs-Obese |
9.348200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.910600E-01 |
| Extreme_Weight-vs-Obese |
7.891000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.146400E-01 |
| Obese-vs-Extreme_Obese |
7.757400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.930000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.970200E-02 |
| Normal-vs-Age(61-80Yrs) |
5.676000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.267400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.827800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.141000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.319000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.423730E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.676200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.062200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.382400E-02 |
| Normal-VS-Type2 PRCC |
1.346780E-01 |
| Normal-VS-KIRP CIMP |
3.907600E-01 |
| Normal-VS-Unclassified PRCC |
5.877400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.455100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.450200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.758000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.413200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.341550E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.519000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.873750E-01 |
| Normal-vs-N1 |
7.854800E-01 |
| Normal-vs-N2 |
8.972100E-02 |
| N0-vs-N1 |
4.603400E-01 |
| N0-vs-N2 |
6.321400E-01 |
| N1-vs-N2 |
3.163600E-01 |
|
|
